Synthesis of a glycoconjugate as a component of a targeted liposomal system for tumor cells.
Cancer therapy remains limited by the low selectivity and systemic toxicity of conventional chemotherapeutic agents, highlighting the need for improved drug delivery systems. In this study, a glucose-derived glycoconjugate was synthesized and incorporated into liposomal nanocarriers to develop a functionalized liposoma...